We are live on ! Find out more
CPV

Canaan Partners VII Portfolio holdings

AUM $32.3M
1-Year Est. Return 154.97%
This Fund
S&P 500
This Quarter Est. Return
-31.69%
1 Year Est. Return
+154.97%
3 Year Est. Return
-20.69%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.6M
AUM Growth
-$30.2M
Cap. Flow
+$106K
Cap. Flow %
0.18%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$19M

Top Sells

Rank Stock Value
1
CMRX
Chimerix, Inc.
CMRX
+$18.9M

Sector Composition

Rank Sector Weight
1 Communication Services 31.71%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRTX
1
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$24.1M 41.13%
1,902,030
– –
TLRA
2
DELISTED
Telaria, Inc.
TLRA
$18.6M 31.71%
7,944,522
– –
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.9M 27.16%
+615,350
New +$19M
CMRX
4
DELISTED
Chimerix, Inc.
CMRX
– –
-861,664
Closed -$18.9M

Similar funds

A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
MIGAR
Madison International Global Alpha Realty New York $25.9M AUM
CWM
Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
TAM
Target Asset Management Singapore $21.4M AUM 66.83% 1-Year Est. Return

Canaan Partners VII's Q3 2014 Portfolio in Review

As of Q3 2014, Canaan Partners VII held 4 positions worth $58.6M, down 34% from $88.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners VII's Q3 2014 filing shows 1 new and 1 closed positions. Its largest new stake was Marinus Pharmaceuticals, Inc: 615,350 shares worth $15.9M. The largest sale was Chimerix, Inc., an estimated $18.9M.

By sector, the portfolio is most concentrated in Communication Services at 32% of assets, down from 42% a quarter earlier, followed by Healthcare.

  • Canaan Partners VII's largest Q3 2014 buy was Marinus Pharmaceuticals, Inc: 615,350 shares worth $15.9M.
  • Canaan Partners VII fully exited Chimerix, Inc. in Q3 2014, selling an estimated $18.9M.
  • Canaan Partners VII's ten largest holdings make up 100% of its $58.6M portfolio in Q3 2014.
  • Canaan Partners VII opened 1 new position and closed 1 in Q3 2014.
  • Canaan Partners VII's portfolio value fell 34% quarter-over-quarter to $58.6M.

Based on Canaan Partners VII's 13F filing for Q3 2014, filed 18 Feb 2015.